Patient and Physician Knowledge of Key Safety Messages
Xarelto (Rivaroxaban) Risk Minimisation Plan Evaluation: Patient and Physician Knowledge of Key Safety Messages
Sponsor: Bayer
Listed as NCT01907048, this observational or N/A phase trial focuses on Anticoagulation and remains completed. Sponsored by Bayer, it has been updated 32 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
32 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — May 2021 [monthly]
Completed
-
May 2020 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 27 earlier versions
-
Apr 2020 — May 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Mar 2020 — Apr 2020 [monthly]
Recruiting
-
Feb 2020 — Mar 2020 [monthly]
Recruiting
-
Jan 2020 — Feb 2020 [monthly]
Recruiting
-
Dec 2019 — Jan 2020 [monthly]
Recruiting
-
Nov 2019 — Dec 2019 [monthly]
Recruiting
-
Oct 2019 — Nov 2019 [monthly]
Recruiting
-
Sep 2019 — Oct 2019 [monthly]
Recruiting
-
Aug 2019 — Sep 2019 [monthly]
Recruiting
-
Jul 2019 — Aug 2019 [monthly]
Recruiting
-
Jun 2019 — Jul 2019 [monthly]
Recruiting
-
May 2019 — Jun 2019 [monthly]
Recruiting
-
Apr 2019 — May 2019 [monthly]
Recruiting
-
Mar 2019 — Apr 2019 [monthly]
Recruiting
-
Feb 2019 — Mar 2019 [monthly]
Recruiting
-
Jan 2019 — Feb 2019 [monthly]
Recruiting
-
Dec 2018 — Jan 2019 [monthly]
Recruiting
-
Nov 2018 — Dec 2018 [monthly]
Recruiting
-
Oct 2018 — Nov 2018 [monthly]
Recruiting
-
Sep 2018 — Oct 2018 [monthly]
Recruiting
-
Aug 2018 — Sep 2018 [monthly]
Recruiting
-
Jul 2018 — Aug 2018 [monthly]
Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Dec 2017 — Apr 2018 [monthly]
Recruiting NA
-
Apr 2017 — Dec 2017 [monthly]
Recruiting NA
-
Jan 2017 — Apr 2017 [monthly]
Recruiting NA
First recorded
Sep 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bayer
- Janssen Research & Development, LLC
- RTI Health Solutions
For direct contact, visit the study record on ClinicalTrials.gov .